Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastomaREYNOLDS, C. Patrick; SEEGER, Robert C.Journal of pediatric hematology/oncology. 2001, Vol 23, Num 3, pp 150-152, issn 1077-4114Article

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma : A new approaches to neuroblastoma therapy consortium studyMATTHAY, Katherine K; TAN, Jessica C; SEEGER, Robert C et al.Journal of clinical oncology. 2006, Vol 24, Num 3, pp 500-506, issn 0732-183X, 7 p.Article

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplificationASGHARZADEH, Shahab; PIQUE-REGI, Roger; SPOSTO, Richard et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 17, pp 1193-1203, issn 0027-8874, 11 p.Article

Enlarged and prominent nucleoli may be indicative of MYCN amplification: A study of neuroblastoma (schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis indexKOBAYASHI, Chie; MONFORTE-MUNOZ, Hector L; GERBING, Robert B et al.Cancer. 2005, Vol 103, Num 1, pp 174-180, issn 0008-543X, 7 p.Article

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma : A Children's Cancer Group studySEEGER, Robert C; REYNOLDS, C. Patrick; GALLEGO, Richard et al.Journal of clinical oncology. 2000, Vol 18, Num 24, pp 4067-4076, issn 0732-183XArticle

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and OncogenicityBOSSE, Kristopher R; DISKIN, Sharon J; DIAMOND, Maura et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 8, pp 2068-2078, issn 0008-5472, 11 p.Article

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 ImmunotherapyDELGADO, David C; HANK, Jacquelyn A; YANG, Richard et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9554-9561, issn 0008-5472, 8 p.Article

Interieukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma CellsARIA, Tasnim; LIPING SONG; SHIMADA, Hiroyuki et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 1, pp 329-337, issn 0008-5472, 9 p.Article

De novo identification of MIZ-1 (ZBTB77) encoding a MYC-lnteracting zinc-finger protein as a new favorable neuroblastoma geneIKEGAKI, Naohiko; GOTOH, Takahiro; KUNG, Bing et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 6001-6009, issn 1078-0432, 9 p.Article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-A report from the Children's cancer group studyRUDNICK, Emily; KHAKOO, Yasmin; ANTUNES, Nuno L et al.Medical and pediatric oncology. 2001, Vol 36, Num 6, pp 612-622, issn 0098-1532Article

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-A report from the children's cancer groupCOOPER, Robert; KHAKOO, Yasmin; MATTHAY, Katherine K et al.Medical and pediatric oncology. 2001, Vol 36, Num 6, pp 623-629, issn 0098-1532Article

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid : A Children's Oncology Group StudyMATTHAY, Katherine K; REYNOLDS, C. Patrick; SEEGER, Robert C et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1007-1013, issn 0732-183X, 7 p.Article

An integrated cross-platform prognosis study on neuroblastoma patientsCHEN, Qing-Rong; SONG, Young K; WEI, Jun S et al.Genomics (San Diego, Calif.). 2008, Vol 92, Num 4, pp 195-203, issn 0888-7543, 9 p.Article

Impact of radiotherapy for high-risk neuroblastoma: A children's cancer group studyHAAS-KOGAN, Daphne A; SWIFT, Patrick S; SELCH, Michael et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 28-39, issn 0360-3016, 12 p.Article

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcγRII (CD32) and Mac-1 (CD 11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosisMETELITSA, Leonid S; GILLIES, Stephen D; SUPER, Michael et al.Blood. 2002, Vol 99, Num 11, pp 4166-4173, issn 0006-4971Article

Homozygous deletion of CDKN2A (p16^INK4a/p14^ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaTHOMPSON, Patricia M; MARIS, John M; HOGARTY, Michael D et al.Cancer research (Baltimore). 2001, Vol 61, Num 2, pp 679-686, issn 0008-5472Article

Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell lineANDERSON, Clarke P; SEEGER, Robert C; SATAKE, Noriko et al.Journal of pediatric hematology/oncology. 2001, Vol 23, Num 8, pp 500-505, issn 1077-4114Article

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic NeuroblastomaASGHARZADEH, Shahab; SALO, Jill A; WAKAMATSU, Peter et al.Journal of clinical oncology. 2012, Vol 30, Num 28, pp 3525-3532, issn 0732-183X, 8 p.Article

Sparse representation and Bayesian detection of genome copy number alterations from microarray dataPIQUE-REGI, Roger; MONSO-VARONA, Jordi; ORTEGA, Antonio et al.Bioinformatics (Oxford. Print). 2008, Vol 24, Num 3, pp 309-318, issn 1367-4803, 10 p.Article

Chromosome 1p and 11q deletions and outcome in neuroblastomaATTIYEH, Edward F; LONDON, Wendy B; BRODEUR, Garrett M et al.The New England journal of medicine. 2005, Vol 353, Num 21, pp 2243-2253, issn 0028-4793, 11 p.Article

GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaROBERTS, Stephen S; MORI, Motomi; RODLAND, Matthew J et al.Journal of clinical oncology. 2004, Vol 22, Num 20, pp 4127-4134, issn 0732-183X, 8 p.Article

TrkA expression in peripheral neuroblastic tumors: Prognostic significance and biological relevanceSHIMADA, Hiroyuki; NAKAGAWA, Atsuko; PETERS, Julius et al.Cancer. 2004, Vol 101, Num 8, pp 1873-1881, issn 0008-543X, 9 p.Article

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrowHOON, Dave S. B; KUO, Christine T; SHENGHUA WEN et al.The American journal of pathology. 2001, Vol 159, Num 2, pp 493-500, issn 0002-9440Article

Neuroblastoma of Undifferentiated Subtype, Prognostic Significance of Prominent Nucleolar Formation, and MYC/MYCN Protein Expression: A Report from the Children's Oncology GroupWANG, Larry L; SUGANUMA, Rie; PARK, Julie R et al.Cancer. 2013, Vol 119, Num 20, pp 3718-3726, issn 0008-543X, 9 p.Article

Novel cancer vaccine based on genes of Salmonella pathogenicity island 2GUOSHENG XIONG; HUSSEINY, Mohamed I; LIPING SONG et al.International journal of cancer (Print). 2010, Vol 126, Num 11, pp 2622-2634, issn 0020-7136, 13 p.Article